SEC Form 4 · accession 0001144204-18-061798
INTERCEPT PHARMACEUTICALS, INC. · ICPT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jerome Benedict Durso
Officer — Chief Operating Officer
Period of report
Nov 23, 2018
Accepted (ET)
Nov 27, 2018 · 7:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001270073
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 23, 2018 | F | 460 | $111.07 | D | 26,184 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares of common stock withheld to satisfy taxes associated with the vesting of restricted stock.
Remarks
Exhibit 24.1 - Power of Attorney